TipRanks
Go Ultimate55% OFF

Immunovant (IMVT) Cash flow

Immunovant Cash Flow

IMVT's free cash flow for Q1 2027 was $-124.41M. For the 2027 fiscal year, IMVT's free cash flow was increased by $0.00 and operating cash flow was $-124.41M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowMar 26Mar 25Mar 24Mar 23Mar 22
$ -407.31M$ -375.87M$ -214.23M$ -188.19M$ -106.11M
$ -8.00K$ -759.00K$ -360.00K$ -197.00K$ -254.00K
$ 595.76M$ 454.49M$ 472.43M$ 70.89M$ 200.13M
$ 902.11M$ 713.97M$ 635.37M$ 376.53M$ 493.82M
$ -407.32M$ -376.63M$ -214.59M$ -188.39M$ -106.37M

Currency in USD

Immunovant Cash Flow

-500M-250M0250M500M750M201820192020202120222023202420252026OperatingInvestingFinancing